Nimble Diagnostics
3 known investors
Find your way into Nimble Diagnostics
Sign up to see every warm intro you have to Nimble Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nimble Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DX Nimble develops the Nimble System, a non-invasive, non-ionizing point-of-care device that helps clinicians detect stent complications such as blockages or fractures before symptoms appear. It targets cardiovascular care, providing portable monitoring for patients with implanted stents.
Investors · 3
Grow Venture PartnersreportedBarcelona · $108K – $216K
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Nimble Diagnostics do?
- DX Nimble develops the Nimble System, a non-invasive, non-ionizing point-of-care device that helps clinicians detect stent complications such as blockages or fractures before symptoms appear. It targets cardiovascular care, providing portable monitoring for patients with implanted stents.
- Who are Nimble Diagnostics's investors?
- Nimble Diagnostics's investors include Ship2B, SpinLab, Grow Venture Partners.



